Detection of genetic alterations in primary bladder carcinoma with dual-color and multiplex fluorescence in situ hybridization

Cancer Genetics and Cytogenetics

Volumn 149, Issue 2, 2004, Pages 107-113

  Stamouli, Maria I ^a   Panani, Anna D ^a   Ferti, Angeliki D ^b   Petraki, Constantina ^a   Oliver, R T D ^c   Raptis, Sotirios A ^a   Young, Bryan D ^d  

^a UNIVERSITY OF ATHENS   (Greece)

^b SOTIRIA GENERAL HOSPITAL   (Greece)

^c ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^d QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLADDER CARCINOMA; CHROMOSOME 11; CHROMOSOME 17; CHROMOSOME 8; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOGENETICS; FEMALE; FLUORESCENCE; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN SITU HYBRIDIZATION; MALE; PRIORITY JOURNAL; SEX CHROMOSOME; X CHROMOSOME; Y CHROMOSOME;

CARCINOMA; CHROMOSOME ABERRATIONS; CHROMOSOME PAINTING; FEMALE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; URINARY BLADDER NEOPLASMS;

EID: 1442324402     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-4608(03)00303-0     Document Type: Article

References (42)

1. Gibas Z., Gibas L. Cytogenetics of bladder cancer. Cancer Genet Cytogenet. 95:1997;108-115.
2. Young R.H. Pathology of bladder cancer. Vogelzang N. Comprehensive textbook of genitourinary oncology. 1996;326-337 Williams and Wilkins, Baltimore, MD.
3. Sandberg A.A., Berger C.S. Review of chromosome studies in urological tumors: II. Cytogenetics and molecular genetics of bladder cancer. J Urol. 151:1994;545-560.
4. Gibas Z., Prout G., Connolly J.G., Pontes J.E., Sandberg A.A. Nonrandom chromosomal changes in transitional cell carcinoma of the bladder. Cancer Res. 44:1984;1257-1264.
5. Atkin N.B., Baker M.C. Cytogenetic study of ten carcinomas of the bladder: involvement of chromosomes 1 and 11. Cancer Genet Cytogenet. 15:1985;253-268.
6. Smeets W., Pauwels R., Laarakkers L., Debruyne F., Geraedts J. Chromosomal analysis of bladder cancer: III. Nonrandom alterations. Cancer Genet Cytogenet. 29:1987;29-41.
7. Vanni R., Scarpa R.M., Nieddu M., Usai E. Cytogenetic investigation on 30 bladder carcinomas. Cancer Genet Cytogenet. 30:1988;35-42.
8. Atkin N.B., Fox M.F. 5q deletion: the sole chromosome change in a carcinoma of the bladder. Cancer Genet Cytogenet. 46:1990;129-131.
9. Fadl-Elmula I., Kytola S., Pan Y., Lui W.O., Derienzo G., Forsberg L., Mandahl N., Gorunova L., Bergerheim U.S., Heim S., Larsson C. Characterization of chromosomal abnormalities in uroepithelial carcinomas by G-banding, spectral karyotyping and FISH analysis. Int J Cancer. 92:2001;824-831.
10. Fadl-Elmula I., Gorunova L., Mandahl N., Elfving P., Lundgren R., Mitelman F., Heim S. Karyotypic characterization of urinary bladder transitional cell carcinomas. Genes Chromosomes Cancer. 29:2000;256-265.
11. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet]. Updated February 2003. Available at: http://cgap.nci.nih.gov/Chromosomes/Mitelman.
12. Mostofi F.K., Sobin L.H., Torloni H. Histological typing of urinary bladder tumors. 1st edition. International Histological Classification of Tumors 10. 1973;World Health Organization, Geneva.
13. Stamouli M.I., Ferti A.D., Panani A.D., Raftakis J., Consoli C., Raptis S.A., Young B.D. Application of multiplex fluorescence in situ hybridization in the cytogenetic analysis of primary gastric carcinoma. Cancer Genet Cytogenet. 135:2002;23-27.
14. Hopman A.H., Ramaekers F.C., Raap A.K., Beck J.L., Devilee P., van der Ploeg M., Vooijs G.P. In situ hybridization as a tool to study numerical chromosome aberrations in solid bladder tumors. Histochemistry. 89:1988;307-316.
15. Mitelman F. An international system for human cytogenetic nomenclature. 1995;S. Karger, Basel.
16. Sauter G., Gasser T.C., Moch H., Richter J., Jiang F., Albrecht R., Novotny H., Wagner U., Bubendorf L., Mihatsch M.J. DNA aberrations in urinary bladder cancer detected by flow cytometry and FISH. Urol Res. 25:(Suppl 1):1997;S37-S43.
17. Berger C.S., Sandberg A.A., Todd I.A.D., Pennington R.D., Haddad F.S., Hecht B.K., Hecht F. Chromosomes in kidney, ureter and bladder cancer. Cancer Genet Cytogenet. 23:1986;1-24.
18. Yu D.S., Chen H.I., Chang S.Y. Chromosomal aberrations in transitional cell carcinoma: its correlation with tumor behavior. Urol Int. 69:2002;129-135.
19. Milasin J., Micic M., Micic S., Diklic V. Distribution of marker chromosomes in relation to histologic grade in bladder cancer. Cancer Genet Cytogenet. 42:1989;135-142.
20. Trent J.M., Stanisic T., Olson S. Cytogenetic analysis of urologic malignancies: study of tumor colony forming cells and premature chromosome condensation. J Urol. 131:1984;146-151.
21. Babu V.M., Lutz M.D., Miles B.J., Farah R.N., Weiss L., Van Dyke D.L. Tumor behavior in transitional cell carcinoma of the bladder in relation to chromosomal markers and histopathology. Cancer Res. 47:1987;6800-6805.
22. Yu D.S., Hsieh D.S., Chang S.Y. Detection of chromosomal alterations in bladder cancer by comparative genomic hybridization. BJU Int. 87:2001;889-893.
23. Zhao J., Richter J., Wagner U., Roth B., Schraml P., Zellweger T., Ackermann D., Schmid U., Moch H., Milatsch M.J., Gasser T.C., Sauter G. Chromosomal imbalances in noninvasive papillary bladder neoplasms (pTa). Cancer Res. 59:1999;4658-4661.
24. Huret JL, Léonard C. Bladder: transitional cell carcinoma. In: Atlas of Genetics and Cytogenetics in Oncology and Haematology [Internet]. Updated October 2000. Available at: http://www.infobiogen.fr/services/ chromcancer/Tumors/blad5001.html.
25. Neuhaus M., Wagner U., Schmid U., Ackermann D., Zellweger T., Ma R., Alund G., Knonagel H., Rist M., Moch H., Mihatsch M.J., Gasser T., Sauter G. Polysomies but not Y chromosome losses have prognostic significance in pTa/pT1 urinary bladder cancer. Hum Pathol. 30:1999;81-86.
26. Sandberg A.A. The chromosomes in human cancer and leukemia. 1st edition:1980;Elsevier, New York.
27. Betz J., Meloni A., Sandberg A.A. FISH studies of the Y chromosome in male urinary cells. Cancer Genet Cytogenet. 88:1996;155-157.
28. Speicher M.R., Gwyn Ballard S., Ward D. Karyotyping human chromosomes by combinatorial multi-fluor FISH. Nat Genet. 12:1996;368-375.
29. Ashman J.N.E., Brigham J., Cowen M.E., Bahia H., Greenman J., Lind M., Cawkwell L. Chromosomal alterations in small cell lung cancer revealed by multicolor fluorescence in situ hybridization. Int J Cancer. 102:2002;230-236.
30. Bayani J., Zielenska M., Pandita A., Al-Romaih K., Karaskova J., Harrison K., Bridge J.A., Sorensen P., Thorner P., Squire J.A. Spectral karyotyping identifies recurrent complex rearrangements of chromosomes 8, 17, and 20 in osteosarcomas. Genes Chromosomes Cancer. 36:2003;7-16.
31. Bayani J., Brenton J.D., Macgregor P.F., Beheshti B., Albert M., Nallainathan D., Karaskova J., Rosen B., Murphy J., Laframboise S., Zanke B., Squire J.A. Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays. Cancer Res. 62:2002;3466-3476.
32. Adeyinka A., Kytola S., Mertens F., Pandis N., Larsson C. Spectral karyotyping and chromosome banding studies of primary breast carcinomas and their lymph nodes metastases. Int J Mol Med. 5:2000;235-240.
33. Cairns P., Shaw M.E., Knowles M.A. Initiation of bladder cancer may involve deletion of a tumor-suppressor gene on chromosome 9. Oncogene. 8:1993;1083-1085.
34. Ruppert J.M., Tokino K., Sidransky D. Evidence of two bladder cancer suppressor loci on human chromosome 9. Cancer Res. 53:1993;5093-5095.
35. Keen A.J., Knowles M.A. Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Oncogene. 9:1994;2083-2088.
36. Devlin J., Keen A.J., Knowles M.A. Homozygous deletion mapping at 9p21 in bladder carcinoma defines a critical region within 2 cM of IFNA. Oncogene. 9:1994;2757-2760.
37. Strefford J.C., Lillington D.M., Steggall M., Lane T.M., Nouri A.M.E., Young B.D., Oliver R.T.D. Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization. Cancer Genet Cytogenet. 135:2002;139-146.
38. Berrozbe G., Miro R., Caballin M.R., Salvador J., Egozcue J. Trisomy 7 may be a primary change in noninvasive transitional cell carcinoma of the bladder. Cancer Genet Cytogenet. 50:1990;9-14.
39. Sandberg A.A. Chromosome changes in bladder cancer: clinical and other correlations. Cancer Genet Cytogenet. 19:1986;163-175.
40. Gibas Z., Prout G.R., Pontes J.E., Connolly J.G., Sandberg A.A. A possible specific chromosome change in transitional cell carcinoma of the bladder. Cancer Genet Cytogenet. 19:1986;229-238.
41. Wagner U., Bubendorf L., Gasser T.C., Moch H., Görög J.P., Richter J., Mihatsch M.J., Waldman F.M., Sauter G. Chromosome 8p deletions are associated with invasive tumor growth in urinary bladder cancer. Am J Pathol. 151:1997;753-759.
42. Keegan P.E., Lunec J. Neal DE. p53 and p53-regulated genes in bladder cancer. Br J Urol. 82:1998;710-720.